Chiral Technologies Acquires Diffinity Genomics

06-Aug-2015 - USA

Chiral Technologies, part of Daicel Corporation, announces the acquisition of the assets of Diffinity Genomics®.

Diffinity Genomics has developed novel technology for the purification of nucleic acids, which formed the foundation for their products in DNA purification markets. The Diffinity RapidTip® technology provides a method for rapid purification of amplified DNA fragments from Polymerase Chain Reaction (PCR) in a single step.

As a new business unit of Chiral Technologies, Diffinity’s product portfolio demonstrates Chiral Technologies’ commitment to providing the health sciences industry with innovative separation technologies and ensures our customers will have access to new opportunities in DNA purification.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances